{"api":"v1","generated_at":"2026-10-01T02:32:44.222Z","licence":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"TOLL, with a link to the page cited"},"page":"https://tollindex.com/e/api-magentlab-com-api-calc-aap-tsb-c4f99e","pinned_page":"https://tollindex.com/e/api-magentlab-com-api-calc-aap-tsb-c4f99e/at/2026-09-30T22-14Z","pinned":false,"method":"https://tollindex.com/ledger/method","snapshot_at":"2026-09-30T22:14:11.940Z","snapshot_stamp":"2026-09-30T22-14Z","endpoint":{"slug":"api-magentlab-com-api-calc-aap-tsb-c4f99e","canonical_url":"https://api.magentlab.com/api/calc/aap_tsb","resource":"https://api.magentlab.com/api/calc/aap_tsb","http_method":"POST","type":"http","x402_version":2,"registries":["cdp"],"primary_registry":"cdp","curated_by_coinbase":false,"description":"AAP 2022 Kemper KAS 10 intensive phototherapy threshold from Supplemental Tables 1 and 2 by completed GA, age in hours, TSB, and caller-assigned extra neurotoxicity risk factors. Linear interpolation between tabulated hours. Do not subtract conjugated bilirubin. Not a phototherapy order. magent does not assay TSB.","service_name":"magent","declared_category":null,"declared_tags":["aap-2022","phototherapy","neonatal","bilirubin","hyperbilirubinemia"],"route_template":null,"registry_updated":"2026-09-28T15:18:42.894Z"},"derived":{"note":"fields no registry supplies; TOLL derives them and marks them derived on the page","title":"calc aap tsb","category":"other","first_observed_by_toll":"2026-09-28T13:51:25.436Z","last_observed_by_toll":"2026-09-30T22:14:11.940Z","observation_began":"2026-09-10"},"presence":{"listed_now":true,"first_absent_at":null,"delisting_confirmed_at":null,"events":[{"registry":"cdp","at":"2026-09-28T13:51:25.437Z","event":"listed"}]},"accepts":[{"registry":"cdp","ordinal":0,"network":"eip155:8453","asset":"0x833589fcd6edb6e08f4c7c32d4f71b54bda02913","asset_name":"USD Coin","symbol":"USDC","decimals":6,"amount_display":"0.005 USDC","amount_units":0.005,"decimals_known":true,"pay_to":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","scheme":"exact"}],"counters":{"observed_at":"2026-09-30T22:14:11.940Z","calls_30d":2,"unique_payers_30d":1,"last_called_at":"2026-09-28T15:18:42.762Z"},"validation":{"latest":{"observed_at":"2026-09-30T08:46:29.200Z","state":"pass","failed_checks":[],"endpoint_http_status":402,"run_id":"daily-2026-09-30"},"uptime":[{"days":7,"observed":3,"passed":3,"ratio":1},{"days":30,"observed":3,"passed":3,"ratio":1},{"days":90,"observed":3,"passed":3,"ratio":1}],"history_90d":[{"observed_at":"2026-09-30T08:46:29.200Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-30","state_changed":false},{"observed_at":"2026-09-29T20:52:15.038Z","state":"pass","failed_checks":[],"run_id":"daily-2026-09-29","state_changed":false},{"observed_at":"2026-09-28T16:48:28.196Z","state":"pass","failed_checks":[],"run_id":"new-after-daily-2026-09-28","state_changed":true}]},"seller":{"wallet":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","page":"https://tollindex.com/seller/0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","endpoints":844,"hosts":1},"reports":0,"registry_record":{"cdp":[{"tags":["aap-2022","phototherapy","neonatal","bilirubin","hyperbilirubinemia"],"type":"http","accepts":[{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2","paymentFlow":"upfront","resourceUrl":"https://api.magentlab.com/api/calc/aap_tsb","assetTransferMethod":"eip3009"},"payTo":"0x836Be278f1739fB4308091cD1852F7971Bc19Ee2","amount":"5000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":600}],"quality":{"lastCalledAt":"2026-09-28T15:18:42.762Z","l30DaysTotalCalls":2,"l30DaysUniquePayers":1},"resource":"https://api.magentlab.com/api/calc/aap_tsb","extensions":{"bazaar":{"info":{"input":{"body":{"items":[{"sepsis":false,"age_hours":48,"tsb_mg_dl":17,"albumin_lt_3":false,"g6pd_deficiency":false,"gestational_age_weeks":40,"clinical_instability_24h":false,"other_hemolytic_condition":false,"isoimmune_hemolytic_disease":false},{"sepsis":false,"age_hours":48,"tsb_mg_dl":17,"albumin_lt_3":false,"g6pd_deficiency":false,"gestational_age_weeks":40,"clinical_instability_24h":false,"other_hemolytic_condition":false,"isoimmune_hemolytic_disease":false}]},"type":"http","method":"POST"},"output":{"type":"json","example":{"path":"/api/calc/aap_tsb","count":2,"items":[{"sepsis":false,"formula":"aap_tsb","citation":{"id":"kemper-2022-aap-hyperbilirubinemia","doi":"10.1542/peds.2022-058859","pmid":"35927462","title":"Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation","source":"Pediatrics. 2022;150(3):e2022058859","authors":"Kemper AR, Newman TB, Slaughter JL, et al."},"age_hours":48,"tsb_mg_dl":17,"components":[{"met":false,"factor":"any_neurotoxicity_risk_factor"},{"met":true,"value":17,"factor":"above_phototherapy_threshold"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","albumin_lt_3":false,"g6pd_deficiency":false,"formula_expression":"Kemper 2022 KAS 10 intensive phototherapy threshold (mg/dL) from Supplemental Table 1 when the caller assigns no neurotoxicity risk factors other than gestational age, or Supplemental Table 2 when any additional listed factor is assigned. Table 1 curves are completed GA 35, 36, 37, 38, 39, and ≥40 weeks. Table 2 curves are 35, 36, 37, and ≥38 weeks. Age is in hours (tabulated hourly from 1 through 336); interpolate linearly between adjacent tabulated hours. Use total serum bilirubin; do not subtract direct-reacting or conjugated bilirubin. Gestational age <38 weeks is already in the GA-specific curve — do not apply Table 2 solely for prematurity. Not a phototherapy or exchange order. magent does not assay TSB","supplemental_table":1,"tsb_minus_threshold":0,"gestational_age_group":"40_or_more","gestational_age_weeks":40,"clinical_instability_24h":false,"other_hemolytic_condition":false,"isoimmune_hemolytic_disease":false,"above_phototherapy_threshold":true,"phototherapy_threshold_mg_dl":17,"any_neurotoxicity_risk_factor":false},{"sepsis":false,"formula":"aap_tsb","citation":{"id":"kemper-2022-aap-hyperbilirubinemia","doi":"10.1542/peds.2022-058859","pmid":"35927462","title":"Clinical Practice Guideline Revision: Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation","source":"Pediatrics. 2022;150(3):e2022058859","authors":"Kemper AR, Newman TB, Slaughter JL, et al."},"age_hours":48,"tsb_mg_dl":17,"components":[{"met":false,"factor":"any_neurotoxicity_risk_factor"},{"met":true,"value":17,"factor":"above_phototherapy_threshold"}],"disclaimer":"Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.","albumin_lt_3":false,"g6pd_deficiency":false,"formula_expression":"Kemper 2022 KAS 10 intensive phototherapy threshold (mg/dL) from Supplemental Table 1 when the caller assigns no neurotoxicity risk factors other than gestational age, or Supplemental Table 2 when any additional listed factor is assigned. Table 1 curves are completed GA 35, 36, 37, 38, 39, and ≥40 weeks. Table 2 curves are 35, 36, 37, and ≥38 weeks. Age is in hours (tabulated hourly from 1 through 336); interpolate linearly between adjacent tabulated hours. Use total serum bilirubin; do not subtract direct-reacting or conjugated bilirubin. Gestational age <38 weeks is already in the GA-specific curve — do not apply Table 2 solely for prematurity. Not a phototherapy or exchange order. magent does not assay TSB","supplemental_table":1,"tsb_minus_threshold":0,"gestational_age_group":"40_or_more","gestational_age_weeks":40,"clinical_instability_24h":false,"other_hemolytic_condition":false,"isoimmune_hemolytic_disease":false,"above_phototherapy_threshold":true,"phototherapy_threshold_mg_dl":17,"any_neurotoxicity_risk_factor":false}]}},"iconUrl":"https://api.magentlab.com/favicon.ico"},"schema":{"type":"object","$schema":"https://json-schema.org/draft/2020-12/schema","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"body":{"type":"object","required":["items"],"properties":{"items":{"type":"array","items":{"type":"object","required":["gestational_age_weeks","age_hours","tsb_mg_dl","isoimmune_hemolytic_disease","g6pd_deficiency","other_hemolytic_condition","sepsis","albumin_lt_3","clinical_instability_24h"],"properties":{"sepsis":{"type":"boolean","description":"Caller-assigned sepsis or suspected sepsis from Kemper 2022 Table 2. true or false. magent does not diagnose sepsis."},"age_hours":{"type":"number","description":"Chronologic age in hours (1-336). Supplemental Tables 1 and 2 are tabulated hourly; ages between adjacent hours are linearly interpolated. Hour 0 is not tabulated. magent does not convert days."},"tsb_mg_dl":{"type":"number","description":"Total serum bilirubin in mg/dL (0-40). Use TSB; do not subtract direct-reacting or conjugated bilirubin. magent does not assay TSB."},"albumin_lt_3":{"type":"boolean","description":"Caller-assigned albumin <3.0 g/dL from Kemper 2022 Table 2. true or false. magent does not assay albumin."},"g6pd_deficiency":{"type":"boolean","description":"Caller-assigned glucose-6-phosphate dehydrogenase (G6PD) deficiency from Kemper 2022 Table 2. true or false. magent does not assay G6PD."},"gestational_age_weeks":{"type":"integer","description":"Completed gestational age in weeks, integer 35-45. Table 1 uses distinct curves for 35, 36, 37, 38, 39, and ≥40. Table 2 groups ≥38 together. magent does not convert days."},"clinical_instability_24h":{"type":"boolean","description":"Caller-assigned significant clinical instability in the previous 24 hours from Kemper 2022 Table 2. true or false. magent does not examine the infant."},"other_hemolytic_condition":{"type":"boolean","description":"Caller-assigned other hemolytic condition (Kemper 2022 Table 2, same neurotoxicity-risk row as isoimmune disease and G6PD deficiency). true or false."},"isoimmune_hemolytic_disease":{"type":"boolean","description":"Caller-assigned isoimmune hemolytic disease (positive direct antiglobulin test) from Kemper 2022 Table 2. true or false. magent does not interpret DAT."}}},"maxItems":25,"minItems":1}},"additionalProperties":false},"type":{"type":"string","const":"http"},"method":{"type":"string","const":"POST"},"headers":{"type":"object","additionalProperties":{"type":"string"}}},"additionalProperties":false},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"type":"object"}}}}}}},"description":"AAP 2022 Kemper KAS 10 intensive phototherapy threshold from Supplemental Tables 1 and 2 by completed GA, age in hours, TSB, and caller-assigned extra neurotoxicity risk factors. Linear interpolation between tabulated hours. Do not subtract conjugated bilirubin. Not a phototherapy order. magent does not assay TSB.","lastUpdated":"2026-09-28T15:18:42.894Z","serviceName":"magent","x402Version":2}]}}